Homepage
Open in app
Sign in
Get started
Vitae Evidence
Find Actionable Personalized Medicine Evidence.
Clinical Studies
Product Updates
Privacy & Security
Health Economics
vitae-evidence.com
Follow
ChatGPT for unlocking Outcomes from Clinical Trials
ChatGPT for unlocking Outcomes from Clinical Trials
This post was written in February 2023 - it is still relevant for the public free version based on GPT 3.5, however it does not assess…
Amelie
Jul 9, 2023
The EU policy debates that could secure the data ecosystems enabling equitable access to treatment.
The EU policy debates that could secure the data ecosystems enablin...
A lot is happening in the health-related legislation landscape in Europe, which some described as a once-in-a-generation opportunity:
Amelie
Nov 5, 2022
Trending
Nordics inequity in reimbursement of personalised medicine and how Digital Health can tackle these.
Nordics inequity in reimbursement of personalised medicine and how Digital Health can tackle these.
Why must Norwegians wait longer than Danes to access new medicines? How Digital Health can support the most optimal outcome-based reimbursm
Amelie
May 1, 2022
How Translational Bioinformatics and Digital Health will contribute to increased opportunities for…
How Translational Bioinformatics and Digital Health will contribute to increased opportunities for…
The political paper “Action Plan for Clinical Studies (2021–2025)” was recently released in Norway by the Ministry of Health and Care…
Amelie
Nov 20, 2021
Better use of health data in clinical trials.
Better use of health data in clinical trials.
The political paper “Action Plan for Clinical Studies (2021–2025)” was recently released in Norway by the Ministry of Health and Care…
Amelie
Apr 11, 2022
What is informed consent in Digital Health for Personalised Medicine?
What is informed consent in Digital Health for Personalised Medicine?
5 bullets points to collect the Informed Consent
Amelie
Nov 20, 2021
About Vitae Evidence
Latest Stories
Archive
About Medium
Terms
Privacy
Teams
